Open AccessInfluence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non–Small-Cell Lung Cancer
Author(s) -
Charu Aggarwal,
Christiana Davis,
Rosemarie Mick,
Jeffrey C. Thompson,
Saman Ahmed,
Seth Jeffries,
Stephen Bagley,
Peter Gabriel,
Tracey L. Evans,
Joshua Bauml,
Christine Ciunci,
Evan Alley,
Jennifer J.D. Morrissette,
Roger B. Cohen,
Erica L. Carpenter,
Corey J. Langer
Publication year - 2018
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.405
H-Index - 22
ISSN - 2473-4284
DOI - 10.1200/po.18.00107
Subject(s) - t790m , lung cancer , medicine , epidermal growth factor receptor , oncology , cancer , mutation , gene , biology , genetics , gefitinib
TP53 mutation (MT) in epidermal growth factor receptor ( EGFR ) -MT non-small cell lung cancer (NSCLC) is associated with poor response to targeted therapy; however, its impact on survival is not clearly established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom